Novavax Stock Target Price and Analyst Consensus

NVAX Stock  USD 8.40  0.13  1.52%   
The current analyst and expert consensus on Novavax is Buy, with 2 strong buy opinions. The current projected Novavax target price consensus is 16.00 with 6 analyst opinions. Check out Macroaxis Advice on Novavax to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.
The most common way Novavax analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Novavax executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Novavax. We strongly encourage you to use your own analysis of Novavax to validate this buy or sell advice. Novavax buy-or-sell recommendation module provides average expert sentiment on the projected Novavax target price to derive its highest and lowest estimates based on projected price volatility of 4.2774.
Lowest Forecast
14.56
Highest Forecast
17.76
Target Price
16
At this time, Novavax's Gross Profit is fairly stable compared to the past year. Gross Profit Margin is likely to rise to 0.46 in 2025, whereas Pretax Profit Margin is likely to drop (0.92) in 2025. At this time, Novavax's Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Current Assets is likely to rise to about 285.5 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (613 M).
  
It's important to approach Novavax's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Novavax Target Price Consensus

Novavax target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Novavax's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   6  Buy
Most Novavax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Novavax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Novavax, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Novavax Target Price Projection

Novavax's current and average target prices are 8.40 and 16.00, respectively. The current price of Novavax is the price at which Novavax is currently trading. On the other hand, Novavax's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Novavax Market Quote on 20th of January 2025

Low Price8.4Odds
High Price8.69Odds

8.4

Target Price

Analyst Consensus On Novavax Target Price

Low Estimate14.56Odds
High Estimate17.76Odds

16.0

Historical Lowest Forecast  14.56 Target Price  16.0 Highest Forecast  17.76
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Novavax and the information provided on this page.

Novavax Analyst Ratings

Novavax's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Novavax stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Novavax's financials, market performance, and future outlook by experienced professionals. Novavax's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Novavax price targets

Novavax's stock target price is an estimate of its future price, usually made by analysts. Using Novavax's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Novavax's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Novavax's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Novavax Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Novavax is a key component of Novavax valuation and have some predictive power on the future returns of a Novavax.
Hype
Prediction
LowEstimatedHigh
4.308.5812.86
Details
Intrinsic
Valuation
LowRealHigh
5.7610.0414.32
Details
Naive
Forecast
LowNextHigh
4.198.4712.74
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.4-0.32-0.2
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Novavax. Your research has to be compared to or analyzed against Novavax's peers to derive any actionable benefits. When done correctly, Novavax's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Novavax.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 30 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Driverless Cars Idea
Driverless Cars
Invested over 60 shares
Momentum Idea
Momentum
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 500 shares

Additional Tools for Novavax Stock Analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.